FTC, drugstores sue Solvay over delay in generic AndroGel

Atlanta Business Chronicle


The law is creating incentives to bring challenges on more and different types of drugs, noted Stuart Graham, an attorney and Georgia Tech assistant professor.

“A Paragraph IV lawsuit will likely cost a generic manufacturer $5 [million] to $10 million, compared to at least $800 million required for a brand company to develop a drug and bring it to market,” Graham said in a statement.